ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Varmus: NCI Needs To Rethink, Review; Programs Must Be “At A High Level”

November 12, 2010

Plant-Based Diet Associated With Improved Survival

April 25, 2008

Cooperative Groups: Insurers Agree To Cover Patient Care Costs In Group Trials

September 26, 1997

SAIC Begins Transition Of Frederick Operations From Incumbent PRI

March 17, 1995

NIH Policy On Diversity In Sponsored Meetings

June 16, 1995

NIH Director Zerhouni to discuss Roadmap initiatives Feb. 27.

February 20, 2004